The Company & The University Of Western Australia Knows There Is Massive Value In The Patentable MDMA-like Compounds, Hence They Have Patents At A National Filing Stage Worldwide…..A Massive Tick From Me, Many Deals Could & Will Be Struck Here $$$$
Great To See The Fully-funded Preclinical Screening Program For Pain ( PSPP ) For RX7 Is Currently Completing Tier 2 evaluations ( assessment of neurotoxicity and efficacy in acute to chronic pain models ) & Expected To Advance To Tier 3 ( disease-specific models ) in H2,2024. I Still Think This Could Be The Catalyst To A Multi Bagger Here…$$$$
Business As Usual With The Growth Plans For Advanced Treatment and Clinical Service Expansion, Although Currently Cash Burn But Company Making For Growth, With Future Buy Out…Take Over Potential.
A Win Win On All Fronts, As Far As I’m Concerned And Great To Get A Company Update…Which Has Been A Bit Lapse Of Late.
This Is Still Priced At Peanuts For The Monkey’s….What A Bargain!
Cheers
- Forums
- ASX - By Stock
- EMD
- Ann: June 2024 Quarterly Activities Report and Appendix 4C
EMD
emyria limited
Add to My Watchlist
0.00%
!
2.7¢

Ann: June 2024 Quarterly Activities Report and Appendix 4C, page-3
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
2.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $16.50M |
Open | High | Low | Value | Volume |
2.8¢ | 2.8¢ | 2.7¢ | $20.25K | 734.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 126 | 2.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.8¢ | 915113 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 126 | 0.027 |
6 | 634330 | 0.026 |
6 | 2367174 | 0.025 |
7 | 930497 | 0.024 |
10 | 886956 | 0.023 |
Price($) | Vol. | No. |
---|---|---|
0.028 | 915113 | 4 |
0.029 | 690000 | 4 |
0.030 | 147104 | 3 |
0.031 | 94812 | 1 |
0.032 | 92000 | 1 |
Last trade - 12.48pm 02/07/2025 (20 minute delay) ? |
Featured News
EMD (ASX) Chart |
The Watchlist
RAC
RACE ONCOLOGY LTD
Dr Pete Smith, Executive Chairman
Dr Pete Smith
Executive Chairman
SPONSORED BY The Market Online